Entrada Therapeutics Inc

The current institutional shareholding score of Entrada Therapeutics Inc is 7.00, ranking 80 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 80.65%, representing a quarter-over-quarter increase of 2.92%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.56% of shares outstanding, with 7.57% increase in holdings.